πŸ‡ΊπŸ‡Έ FDA
Patent

US 6320022

Adrenomedullin peptides

expired A61KA61K2039/505A61K2039/51

Quick answer

US patent 6320022 (Adrenomedullin peptides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K2039/51, A61K38/00, A61K39/00